Beranda › Hemofilia › Texas › Dallas
Uji klinis Hemofilia di Dallas, TX
4 studi untuk Hemofilia mencari peserta di lokasi sekitar Dallas (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
TG-INSIGHT With Joint POCUS, Hemostatic Potential in Patients With Severe Hemophilia A on Novel Replacement and Substitution FVIII Therapies
Menerima pesertaStudi observasional
- The University of Texas Southwestern Medical Center, Dallas
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Menerima pesertaStudi observasional
- North Texas Hemophilia and Thrombosis Program - Pediatric Program / Center for Cancer & Blood Disorders, Dallas
- North Texas Comprehensive Hemophilia Treatment Center, Dallas
A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B
Menerima pesertaFase 3
- University of Texas - Southwestern Medical Center- Site Number : 8400015, Dallas
Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study
Menerima pesertaFase 4
- UT Southwestern Medical Center, Dallas
Uji klinis Hemofilia di kota lain
- Indianapolis, IN9 studi
- Los Angeles, CA7 studi
- Seattle, WA6 studi
- Cedar Rapids, IA6 studi
- Philadelphia, PA5 studi
- Sacramento, CA4 studi
- Tampa, FL4 studi
- Atlanta, GA4 studi
- Little Rock, AR4 studi
- Greenville, NC4 studi
- Orange, CA4 studi
- San Francisco, CA3 studi
Studi lain di Dallas
- Kanker Payudara55 studi
- Kanker Paru Non-Sel Kecil52 studi
- Kanker Metastatik42 studi
- Gagal Jantung42 studi
- Kanker (semua jenis)37 studi
- Kanker Prostat36 studi
- Kanker Kolorektal33 studi
- Obesitas30 studi
- Kanker Ovarium28 studi
- Kanker Kandung Kemih27 studi
- Kanker Paru27 studi
- Kanker Endometrium24 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.